Australia markets open in 8 hours 31 minutes

Immuron Limited (IMC.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0940+0.0040 (+4.44%)
At close: 02:55PM AEST
Full screen
Previous close0.0900
Open0.0890
Bid0.0910 x 3350000
Ask0.0980 x 10984500
Day's range0.0870 - 0.0940
52-week range0.0650 - 0.1700
Volume332,285
Avg. volume1,481,058
Market cap21.413M
Beta (5Y monthly)1.16
PE ratio (TTM)N/A
EPS (TTM)-0.0200
Earnings date28 Feb 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Presenting on the Emerging Growth Conference 70 Day 1 on May 8 Register Now

    MIAMI, May 07, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 70th Emerging Growth Conference on May 8 & 9, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies t

  • GlobeNewswire

    Immuron Limited to Present at the Emerging Growth Conference

    MELBOURNE, Australia, May 07, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to invite individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference, on Wednesday 8th May. The next Emerging Growth Conference will be presented on Wednesday, 8 May, 2024. This live, interactive online event will give exist

  • GlobeNewswire

    Immuron Director Resignation

    MELBOURNE, Australia, May 03, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, advises that Stephen Anastasiou has resigned from his position as Non-Executive Director effective today to focus on his other business interests. Stephen has served as a Director since 2013 and has provided valued contributions and experienced counsel to the Company. During Stephen’s tenure, Immuron launched Travelan® into the US